TFA versus acetate as a counterion

What counterion means

A counterion is an oppositely charged ion accompanying charged peptide groups in a salt. Under acidic conditions, basic groups at the N terminus and in residues such as lysine or arginine can be protonated and associate with anions. Trifluoroacetate is the anion of trifluoroacetic acid, commonly abbreviated TFA; acetate corresponds to acetic acid. This association does not amount to changing the covalent sequence or acetylating the peptide (Erckes et al., 2025; PMID: 40872554).

Counterion quantity should not be inferred solely by counting basic residues. Erckes and colleagues found TFA above the quantity expected from a stoichiometric charge model in the peptides they analysed. It is therefore useful to distinguish the declared salt form from measured anion content and possible residual excess. A label stating “TFA salt” identifies a chemical category, but cannot replace a quantitative determination (Erckes et al., 2025; PMID: 40872554).

Why TFA occurs after HPLC

TFA is used in solid-phase synthesis for certain deprotection and resin-cleavage steps, and in reversed-phase chromatography as an ion-pairing reagent. Interaction between trifluoroacetate and positive groups assists peptide separation on lipophilic stationary phases. When purified fractions are freeze-dried, that interaction can leave the isolated peptide as a trifluoroacetate salt. Its presence consequently reflects production chemistry rather than a separate peptide sequence (Erckes et al., 2025; PMID: 40872554).

Obtaining acetate requires considering counterion exchange and checking its outcome. Sikora and colleagues prepared acetate, chloride and trifluoroacetate salts of the same sequences, and quantified anions by ion chromatography. For material comparisons, we recommend recording the initial anion, final anion and measured residual TFA; adding acetic acid or changing the preparation name does not itself provide analytical evidence of complete exchange (Sikora et al., 2018; PMID: 29307075).

Solubility: a conditional comparison

Solubility depends on sequence, ionizable groups and the dissolution medium. Recommendations for peptide standards highlight the roles of pH and solvent composition, and the difficulty of setting general rules across sequences. Consequently, we do not propose a universal ranking in which acetate is always more soluble than TFA: comparison should use the same peptide under documented conditions, rather than assuming salt identity determines the outcome (Hoofnagle et al., 2016; PMID: 26719571).

CSP7 provides a concrete example: Sahakijpijarn and colleagues compared its acetate and TFA salts at different pH values. They found no significant solubility differences at several tested points; at pH 8 and 10, the TFA salt was more soluble. This finding shows that counterion comparisons need to specify sequence and medium. It cannot predict the behaviour of other peptides or our preparations, or establish a general preference for TFA (Sahakijpijarn et al., 2019; PMID: 31569515).

Stability and integrity

Stability requires defining the measurement: chemical integrity, recovery in solution or retention of a physical property. For peptide standards, sequence, medium composition, storage and contact surfaces influence results. We recommend comparing both salts with the same method and observing changes against an initial measurement, without assigning superior stability to acetate simply because of its name or because a different sequence behaved favourably (Hoofnagle et al., 2016; PMID: 26719571).

For CSP7, the study linked acetate loss during freeze-drying and storage to pH changes after dissolution and aggregation; composition and processing influenced counterion preservation. Comparison with TFA showed that physical stability could differ between preparations. This is a result conditioned by that sequence and those formulations, rather than a transferable shelf life. We recommend checking integrity and composition following exchange instead of assuming that changing anions guarantees stability (Sahakijpijarn et al., 2019; PMID: 31569515; Erckes et al., 2025; PMID: 40872554).

Interpreting cell assays

Sikora and colleagues compared three salt forms of several peptides in microbiological and cell-cytotoxicity assays. They found differences between salts, but the pattern was inconsistent across sequences. The relevant research conclusion is that counterion identity can be an experimental variable; the study does not justify treating acetate as invariably inert or attributing every difference to free TFA. It supports sequence-specific assessment within the actual assay system (Sikora et al., 2018; PMID: 29307075).

Based on that evidence, we recommend documenting salt form, anion content, peptide content and assay matrix, and considering medium and counterion controls appropriate to the experimental question. Comparisons between salts should maintain peptide molar quantity as a common criterion. These are design considerations for laboratory models, rather than predictions of results for any sequence or substitutions for measurements of the particular preparation being studied (Sikora et al., 2018; PMID: 29307075; Erckes et al., 2025; PMID: 40872554).

Verified references

• Sahakijpijarn S et al. Formulation Composition and Process Affect Counterion for CSP7 Peptide. Pharmaceutics, 2019. PMID: 31569515. DOI: 10.3390/pharmaceutics11100498.
• Erckes V et al. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel), 2025. PMID: 40872554. DOI: 10.3390/ph18081163.
• Sikora K et al. Counter-ion effect on antistaphylococcal activity and cytotoxicity of selected antimicrobial peptides. Amino Acids, 2018. PMID: 29307075. DOI: 10.1007/s00726-017-2536-9.
• Hoofnagle AN et al. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. Clinical Chemistry, 2016. PMID: 26719571. DOI: 10.1373/clinchem.2015.250563.